… While the potential impact of immunotherapy on the risk of COVID-19 and its complications
… of differentiating the overlapping symptoms of COVID-19 from irAEs in patients receiving ICIs …

… COVID-19 and, as it regulates PARP gene expression, the latter is likely to be activated in
COVID-19… and should be the focus of COVID-19 immunotherapy. Potent PARP 1 inhibitors are …

… Taken together, our findings support the hypothesis that immunotherapy combining TPE
and corticosteroids can be effective in the treatment of severe COVID-19-related encephalitis. …

… have been spotlighted nowadays in the regular COVID-19 updates, may be due to … COVID-19.
We aimed to explore the latest updates of immunotherapeutic perspectives of COVID-19 …

… in immunotherapy of COVID-19 are cytokines. The specificity of IL-6 in COVID-19 among …
symptoms in serious COVID-19 patients [11] and in obese patients with COVID-19 who may …

… immunotherapy is a promising approach for treating CD8 + T cell dysfunction in chronic
infections and cancer, 71 adoptive therapy with Tregs may be an effective strategy for COVID-19 …

… discuss the various ways immunotherapies are being deployed to tackle COVID-19, with a …
of the potential damage immunotherapies could have in severe cases of COVID-19, and how …

… In this position paper we clarify how to use AIT in temporal relation to COVID-19 vaccination…
immunotherapy (SCIT). For sublingual immunotherapy (SLIT) and oral immunotherapy (OIT), …

… of immunotherapy for NSCLC patients during the COVID-19 … patients receiving immunotherapy
and the current COVID-19 … The current WHO definition of a confirmed case of COVID-19 …

… in the subgroup of immunotherapy. Therefore, our … of immunotherapy on the development
of severe COVID-19. Recently, Wu et al. observed a higher proportion of severe COVID-19 in …